VTI Share Price Performance
AU$0.066
-0.06 (-46.12%)
Price AU$0.066
Share PriceAU$0.066
VTI Community Narratives
There are no narratives available yet.
Recent VTI News & Updates
No updates
Visioneering Technologies, Inc. Key Details
Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.063
- Gross Margin
- 30.93%
- Net Profit Margin
- -40.22%
- Debt/Equity Ratio
- 0%
Visioneering Technologies, Inc. Competitors
About VTI
- Founded
- 2008
- Employees
- n/a
- CEO
- WebsiteView website
Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.
U.S. Market Performance
- 7 Days: -1.2%
- 3 Months: 13.1%
- 1 Year: 22.8%
- Year to Date: 7.3%
Over the last 7 days, the market has dropped 1.2%, driven by a pullback of 4.7% in the Consumer Discretionary sector. As for the longer term, the market has actually risen by 23% in the last year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading